Jim Simons Royalty Pharma PLC Transaction History

Renaissance Technologies LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $279,817 - $319,252	10,190 New	10,190 $309,000
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $7.55 Million - $9.02 Million	-287,500 Reduced 37.3%	483,200 $13.1 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $15.7 Million - $19.4 Million	-530,200 Reduced 40.76%	770,700 $23.7 Million
Q1 2023 May 12, 2023	BUY	$32.77 - $39.4 $14.2 Million - $17 Million	431,900 Added 49.7%	1,300,900 $46.9 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $34 Million - $38.3 Million	869,000 New	869,000 $34.3 Million
Q2 2022 Aug 12, 2022	SELL	$37.53 - $44.22 $6.9 Million - $8.13 Million	-183,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $23 Million - $26.1 Million	-615,200 Reduced 76.99%	183,900 $7.17 Million
Q4 2021 Feb 11, 2022	BUY	$35.17 - $42.48 $545,135 - $658,440	15,500 Added 1.98%	799,100 $31.8 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $1.63 Million - $1.9 Million	-45,000 Reduced 5.43%	783,600 $28.3 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $33 Million - $38.6 Million	828,600 New	828,600 $34 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.